There’s a lot to look forward to.

Due to successful results in the first phase of our study on the effects of our Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project.

Testing our products to prove clinical efficacy is one of our core values, and something that sets us apart in the industry. Due to successful results in the first phase of our study on the effects of our Lycored Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project. The results of the study showed that subjects who ingested our blend had significantly reduced systolic and diastolic blood pressures and increased retinal capillary blood flow markers. Professor Alon Harris, principal clinical study investigator, believes that “these initial results of the […] study showcase the importance of the development of supplements for eyes and where the future of the vision health industry is heading.” We hope to keep the promising results coming, and we’re excited to see what phase two brings.

Continue reading

Ditching red dye No.3: Food innovators move toward natural solutions in preparation for US ban

Experts in the color space are ramping up innovation to mitigate the forthcoming red dye No. 3 ban in the US by turning to natural solutions in their formulations.

Here Are Replacements for Banned Color Additives

Whether you’re looking to replace Red 3 & 40, Blue 1 & 2, Yellow 5 & 6 or Green 3, here’s a list of replacements from suppliers.

FDA Red 3 Ban

Deep Dive: FDA to revoke Red No. 3 authorization

January 15th 2025, the FDA announced that they would be revoking their authorizations for Red No. 3 in food and ingested drugs. The Lycored team comments on the situation.

We're here for you

Interested in speaking directly with a member of our team?
Click below to get in touch.

Contact us